Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

More On SKP.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

SkyePharma plc (SKP.L)

-LSE
244.50 Down 0.75(0.31%) 7:12AM EDT
Prev Close:245.25
Open:246.00
Bid:244.25
Ask:244.50
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:243.75 - 247.00
52wk Range:68.00 - 266.00
Volume:30,024
Avg Vol (3m):433,226
Market Cap:112.50M
P/E (ttm):14,382.35
EPS (ttm):0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Headlines

  • No Headlines available for SKP.L at this time.

Key Statistics

Forward P/E (1 yr):0.12
P/S (ttm):180.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :15.35
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC, a drug delivery company, develops, manufactures, and sells oral and inhalation pharmaceutical products. Its marketed products include flutiform and ZYFLO CR for treating asthma; Relvar Ellipta/Breo Ellipta for asthma and COPD; Anor... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback